Boehringer Ingelheim RCV GmbH & Co KG
About Boehringer Ingelheim
Boehringer Ingelheim RCV GmbH & Co KG in Vienna is the center of oncology research and one of the two centers of biopharmaceutical development and production in the international Boehringer Ingelheim group of companies.
Also located at the Vienna site is another subsidiary: Boehringer Ingelheim Pharma Vienna. The company's primary goals are to open up the pharmaceutical markets of Central and Eastern Europe, to provide medical and scientific information and to establish Boehringer Ingelheim products in these markets.
From Vienna, Boehringer Ingelheim serves as a regional center for both the Austrian market and 29 countries in Central and Eastern Europe.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Employees: 10,001+
- Industry : Pharma
Product portfolio of Boehringer Ingelheim
News about Boehringer Ingelheim
Here you will find Boehringer Ingelheim RCV GmbH & Co KG
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
